피부질환 치료에 사용되는 신기법 = Recently developed therapeutic options for skin disorders

다국어 초록 (Multilingual Abstract)

The number of therapeutic options available to dermatologists for skin disorders has grown significantly over the past several years. Incorporating newly developed and recruited therapeutic modalities into the dermatologic field can promote a better overall treatment outcome and patient satisfaction while reducing common side effect. This article focuses to explore the current and new application of various therapeutic options for skin disorders. In particular,some mechanisms of action behind each therapy will be discussed. It is the hope that through this paper, clinicians will feel more comfortable choosing among these treatment options in their everyday practice of dermatology.

참고문헌 (Reference)

1 Scanlon JV, "Ustekinumab: treatment of adult moderate-to-severe chronic plaque psoriasis" 43 : 1456-1465, 2009

2 Gospodarevskaya E, "Ustekinumab for the treatment of moderate to severe psoriasis" 13 (13): 61-66, 2009

3 Frankel AJ, "Treatment of psoriasis in patients with hepatitis C: from the Medical Board of the National Psoriasis Foundation" 61 : 1044-1055, 2009

4 Skurkovich S, "Treatment of alopecia areata with anti-interferon-gamma antibodies" 10 : 283-284, 2005

5 Taylor MN, "The practicalities of photodynamic therapy in acne vulgaris" 160 : 1140-1148, 2009

6 Bos JD, "The millennium criteria for the diagnosis of atopic dermatitis" 7 : 132-138, 1998

7 Shaheedi-Dadras M, "The effect of methylprednisolone pulse-therapy plus oral cyclosporine in the treatment of alopecia totalis and universalis" 11 : 90-93, 2008

8 Schmitt J, "Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature" 3 : 303-318, 2009

9 Sauerbrey A, "Successful immunsuppression in childhood alopecia areata" 223 : 244-245, 2011

10 Robson KJ, "Pulsed-dye laser versus conventional therapy in the treatment of warts: a prospective randomized trial" 43 (43): 275-280, 2000

11 Patel SP, "Profile of ipilimumab and its role in the treatment of metastatic melanoma" 5 : 489-495, 2011

12 Lomax AR, "Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans" 15 : 1428-1518, 2009

13 Zylicz Z, "Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial" 26 : 1105-1112, 2003

14 Muhlemann MF, "Oral spironolactone: an effective treatment for acne vulgaris in women" 115 : 227-232, 1986

15 Busse W, "Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma" 108 : 184-190, 2001

16 Massing AM, "Natural history of warts. A twoyear study" 87 : 306-310, 1963

17 Till SJ, "Mechanisms of immunotherapy" 113 : 1025-1034, 2004

18 Micali G, "Management of cutaneous warts: an evidence-based approach" 5 : 311-317, 2004

19 Morton CA, "Guidelines for topical photodynamic therapy: update" 159 : 1245-1266, 2008

20 Bergasa NV, "Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial" 44 : 1317-1323, 2006

21 Weidinger S, "Filaggrin mutations, atopic eczema, hay fever, and asthma in children" 121 : 1203.e1-1209.e1, 2008

22 Inui S, "Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases" 36 : 323-327, 2009

23 Ohyama M, "Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata" 58 : 154-157, 2010

24 Mounsey AL, "Diagnosing and treating hair loss" 80 : 356-362, 2009

25 Bikle DD, "Development and progression of alopecia in the vitamin D receptor null mouse" 207 : 340-353, 2006

26 Ito T, "Combination therapy with oral PUVA and corticosteroid for recalcitrant alopecia areata" 301 : 373-380, 2009

27 Elias PM, "Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms" 121 : 1337-1343, 2008

28 Garg S, "Alopecia areata: evidence-based treatments" 28 : 15-18, 2009

29 Hood R, "A prospective, randomized pilot evaluation of topical triple antibiotic versus mupirocin for the prevention of uncomplicated soft tissue wound infection" 22 : 1-3, 2004

30 "A new classification of pattern hair loss that is universal for men and women: Basic and specific (BASP) classification" MOSBY-ELSEVIER 57 (57): 37-46, 2007